Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹11.19
0.04 (0.36%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹217 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹9.3+20.3%
52W High₹22.4-50.0%
Current Price
₹11.19
Circuit Limits (5%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹10.63
Upper Circuit₹11.75
Reference Price
₹11.19
Investment Checklist
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹10.37
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹9.09
Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Composite score -43.51 (SELL) with 53.7% confidence
SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
54%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
EMA20
11.55
EMA50
11.81
EMA200
13.68
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows4
Lower Highs4
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹11.72
₹11.99
₹12.24
₹12.79
₹13.06
Support (Below)
₹11.08
₹9.30
Volume Analysis
TrendDECREASING
Change-45.60%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹11.08
3% Risk₹10.85
5% Risk₹10.63
7% Risk (Custom)
₹10.41Technical Levels
1x ATR (Volatility)₹10.71
2x ATR (Swing)₹10.23
3x ATR (Trend)₹9.75
Immediate Support₹11.08
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹428.9 Cr | ₹280.7 Cr | ₹5 Cr | ₹0 |
| Net Profit | ₹-130.1 Cr | ₹-63.2 Cr | ₹-32,93,000 | ₹14.3 Cr |
| EPS | — | ₹-2.82 | ₹-7.85 | ₹0.64 |
| Operating Profit | ₹-151.8 Cr | ₹-61.5 Cr | ₹-30,21,000 | ₹86.9 Cr |
ROE
-11.89%
ROCE
-5.49%
Debt/Equity
0.61
Current Ratio
1.21
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Nectar Lifesciences Limited | ₹11.19 | -0.36% | — | ₹217 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 24 Dec 2025 | Buy Back | BUYBACK |
| 13 Sept 2024 | Annual General Meeting | AGM |
| 14 Sept 2023 | Annual General Meeting | AGM |
| 13 Sept 2022 | Annual General Meeting | AGM |
| 13 Sept 2021 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for NECLIFE
View All
positive
Business Standard - Markets 120d ago
Stocks to Watch today: ACME Solar, Gravita India, Kalpataru, Raymond Realty
Stocks to Watch today, March 13: Aurobindo Pharma, Godrej Properties, KPI Green Energy, JK Lakshmi Cement, Max Financial Services, and Nectar Lifesciences are among the top stocks to remain in focus
ACMESOLARADANIGREENAUROPHARMACLEANMAXENERGYFOCUSGKENERGYGODREJINDGODREJPROPGRAVITAINOXGREENJKCEMENTJKLAKSHMIJMFINANCILKALPATARUKPELKPIGREENMAXINDMFSLNECLIFENTPCGREENRAYMONDRAYMONDRELSAATVIKGLSOLARINDSCapital GoodsChemicals
positive
CNBC TV18 - Markets 120d ago
Nectar Lifesciences signs ₹100-crore loan pact with arm Avensis Exports
Nectar Lifesciences Ltd signed a ₹100-crore, 10-year loan deal at 12% interest with subsidiary Avensis Exports to support its corporate needs. Shares of Nectar Lifesciences Ltd ended marginally lower on Thursday, March 12, by 0.61% 11.35 on the NSE.
NECLIFEHealthcare
positive
Moneycontrol NaNd ago
Stocks to Watch Today: JK Lakshmi Cement, Gravita India, Balaji Amines, Shaily Engineering, Kalpataru, Action Construction Equipment in focus on 13 March
Stocks to Watch, 13 March: Stocks like Shaily Engineering Plastics, JK Lakshmi Cement, Max Financial Services, Manorama Industries, Nectar Lifesciences, Balaji Amines, and KPI Green Energy will be in focus on March 13.
ACEADANIGREENBALAMINESCLEANMAXENERGYFOCUSGARUDAGENCONGKENERGYGRAVITAHGINFRAIL&FSENGGINOXGREENJKCEMENTJKLAKSHMIJMFINANCILKALPATARUKPELKPIGREENMANORAMAMAXINDMBELMFSLNECLIFENTPCGREENSAATVIKGLSATTVAENGGSHAILYCapital GoodsChemicals